Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against
British Journal of Cancer, Published online: 29 November 2023; doi:10.1038/s41416-023-02506-5Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 29, 2023 Category: Cancer & Oncology Authors: Peter Elwood Gareth Morgan John Watkins Majd Protty Malcolm Mason Richard Adams Sunil Dolwani Janet Pickering Christine Delon Marcus Longley Source Type: research

Multivitamin use and all-cause and cause-specific mortality in cancer survivors
British Journal of Cancer, Published online: 28 November 2023; doi:10.1038/s41416-023-02421-9Multivitamin use and all-cause and cause-specific mortality in cancer survivors (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 28, 2023 Category: Cancer & Oncology Authors: Yikyung Park Zeinab Farhat Linda M. Liao Maki Inoue-Choi Erikka Loftfield Source Type: research

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
British Journal of Cancer, Published online: 27 November 2023; doi:10.1038/s41416-023-02502-9Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 27, 2023 Category: Cancer & Oncology Authors: Freya R. Weth Georgia B. Hoggarth Anya F. Weth Erin Paterson Madeleine P. J. White Swee T. Tan Lifeng Peng Clint Gray Source Type: research

EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia
British Journal of Cancer, Published online: 27 November 2023; doi:10.1038/s41416-023-02509-2EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 27, 2023 Category: Cancer & Oncology Authors: Saket Awadhesbhai Patel Md. Khurshidul Hassan Monali Naik Nachiketa Mohapatra Poornima Balan Purna Sai Korrapati Manjusha Dixit Source Type: research

Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis
British Journal of Cancer, Published online: 27 November 2023; doi:10.1038/s41416-023-02501-wLong-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 27, 2023 Category: Cancer & Oncology Authors: Mateus Trinconi Cunha Mariana Carvalho Gouveia Felippe Lazar Neto Laura Testa Paulo Marcelo Hoff Evandro de Azambuja Renata Colombo Bonadio Source Type: research

Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial
British Journal of Cancer, Published online: 23 November 2023; doi:10.1038/s41416-023-02496-4Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 23, 2023 Category: Cancer & Oncology Authors: Hans-Joachim Schmoll Julia Mann Fabian Meinert Benjamin Garlipp Kersten Borchert Arndt Vogel Eray Goekkurt Ulrich Kaiser Heinz-Gert Hoeffkes J örn Rüssel Stephan Kanzler Thomas Edelmann Helmut Forstbauer Thomas G öhler Carla Hannig Bert Hildebrandt Car Source Type: research

Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden
British Journal of Cancer, Published online: 22 November 2023; doi:10.1038/s41416-023-02499-1Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 22, 2023 Category: Cancer & Oncology Authors: Hanna Mogensen Giorgio Tettamanti Line Elmerdahl Frederiksen Mats Talb äck Juho H ärkonen Karin Modig Camilla Pedersen Anja Kr øyer Elli Hirvonen Anniina Kyr önlahti Mats Heyman Anna S ällfors Holmqvist Henrik Hasle Laura Madanat-Harjuoja Nea Malila Source Type: research

Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
British Journal of Cancer, Published online: 18 November 2023; doi:10.1038/s41416-023-02487-5Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC) (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 18, 2023 Category: Cancer & Oncology Authors: Jimmy L. Zhao Emmanuel S. Antonarakis Heather H. Cheng Daniel J. George Rahul Aggarwal Elyn Riedel Takayuki Sumiyoshi Joseph D. Schonhoft Amanda Anderson Ninghui Mao Samuel Haywood Brooke Decker Tracy Curley Wassim Abida Felix Y. Feng Karen Knudsen Brett Source Type: research

Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
British Journal of Cancer, Published online: 16 November 2023; doi:10.1038/s41416-023-02493-7Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial) (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 16, 2023 Category: Cancer & Oncology Authors: Hiroko Minatogawa Naoki Izawa Kazuhiro Shimomura Hitoshi Arioka Hirotoshi Iihara Mitsuhiro Sugawara Hajime Morita Ayako Mochizuki Shuichi Nawata Keisuke Mishima Ayako Tsuboya Tempei Miyaji Kazunori Honda Ayako Yokomizo Naoya Hashimoto Takeshi Yanagihara J Source Type: research

Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis
British Journal of Cancer, Published online: 16 November 2023; doi:10.1038/s41416-023-02490-wAccuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 16, 2023 Category: Cancer & Oncology Authors: Laura Downham Iman Jaafar Mary Luz Rol Victoria Nyawira Nyaga Joan Valls Armando Baena Li Zhang Marc J. Gunter Marc Arbyn Maribel Almonte Source Type: research

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer
British Journal of Cancer, Published online: 16 November 2023; doi:10.1038/s41416-023-02491-9Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 16, 2023 Category: Cancer & Oncology Authors: Zahra Eslami-S Luis Enrique Cort és-Hernández L éa Sinoquet Ludovic Gauthier Valentin Vautrot Laure Cayrefourcq Laure Avoscan William Jacot St éphane Pouderoux Marie Viala Quentin Dominique Thomas Pierre-Jean Lamy Xavier Quantin Jessica Gobbo Catherin Source Type: research

Comment on “Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia”
British Journal of Cancer, Published online: 16 November 2023; doi:10.1038/s41416-023-02497-3Comment on “Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia” (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 16, 2023 Category: Cancer & Oncology Authors: Gargi Sarode Sachin C. Sarode Source Type: research

APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells
British Journal of Cancer, Published online: 15 November 2023; doi:10.1038/s41416-023-02484-8APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 15, 2023 Category: Cancer & Oncology Authors: Mingjue Chen Tetsuo Mashima Taichi Oishi Yukiko Muramatsu Yosuke Seto Manabu Takamatsu Naomi Kawata Shun Morino Ayane Nakamura Saori Inaba Xunmei Yuan Kohei Maruyama Mai Suzuki Ayana Sato Haruka Yoshida Myung-Kyu Jang Anna Mizutani Kengo Takeuchi Kensei Y Source Type: research

Correction: Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England National Cancer Registry 2012–2016
British Journal of Cancer, Published online: 14 November 2023; doi:10.1038/s41416-023-02486-6Correction: Inequalities in treatment among patients with colon and rectal cancer: a multistate survival model using data from England National Cancer Registry 2012–2016 (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 14, 2023 Category: Cancer & Oncology Authors: Suping Ling Miguel-Angel Luque Fernandez Manuela Quaresma Aurelien Belot Bernard Rachet Source Type: research

Enlarged tumour-draining lymph node with immune-activated profile predict favourable survival in non-metastatic colorectal cancer
British Journal of Cancer, Published online: 13 November 2023; doi:10.1038/s41416-023-02473-xEnlarged tumour-draining lymph node with immune-activated profile predict favourable survival in non-metastatic colorectal cancer (Source: British Journal of Cancer)
Source: British Journal of Cancer - November 13, 2023 Category: Cancer & Oncology Authors: Xu Guan Pu Cheng Ran Wei Jiangtao Li Shuai Jiao Zhixun Zhao Haipeng Chen Zheng Liu Zheng Jiang Zhaoxu Zheng Shuangmei Zou Xishan Wang Source Type: research